Clinical Trial Detail

NCT ID NCT04233567
Title Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Sameek Roychowdhury
Indications

Advanced Solid Tumor

cholangiocarcinoma

Therapies

Infigratinib

Age Groups: adult senior

Additional content available in CKB BOOST